Genomic & Biopharma NewsPersonalized cancer vaccine improves outcomes for patients with AML, clinical study shows
A personalized cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukemia (AML), a potentially lethal blood cancer, in a clinical trial led by investigators at Beth Israel Deaconess Medical Center.
|News Medical Life Sciences, 2016-12-09 07:01:15|
Horizon hit by Actimimmune fail in Friedrich’s ataxia
Horizon Pharma shares dropped 20 percent after the company pulled the plug a late-stage trial testing Actimmune as a potential therapy Friedreich's ataxia.
|PharmaTimes, 2016-12-09 06:51:39|
IBM and Rice University create prototype of Watson-enabled robot for assisting elderly people
IBM Research today announced the creation of the prototype IBM Multi-Purpose Eldercare Robot Assistant (IBM MERA) done in collaboration with Rice University. IBM MERA is a first of a kind Watson-enabled application designed to help assist the elderly and their caregivers.
|News Medical Life Sciences, 2016-12-09 06:51:09|
CRT Pioneer Fund invests in BCL6 project
The Cancer Research Technology Pioneer Fund is making its ninth investment in a project aiming to develop a new class of therapies for patients with diffuse large B-cell lymphoma - a sub-type of Non-Hodgkin Lymphoma (NHL).
|PharmaTimes, 2016-12-09 06:46:40|
ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients
ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral disease, announced today that the Company presented new preclinical data on ABX464, ABIVAX's first-in-class drug candidate for a functional cure of patients with HIV/AIDS, during this week's HIV DART scientific conference in Los Cabos, Mexico.
|News Medical Life Sciences, 2016-12-09 06:42:31|
Study shows experimental treatment not superior to standard therapy for head and neck cancer
Results of the largest Canadian clinical trial to date comparing standard treatment for locally advanced squamous cell head and neck cancer with an experimental treatment, did not show the new treatment is superior.
|News Medical Life Sciences, 2016-12-09 06:34:56|
Research findings could pave way for synthesis of biologically active oligopeptides
The research community and pharmaceutical industry have had a long-standing interest in developing peptide-based therapeutics owing to their high target specificity, potent activity, and small size relative to protein-based biologics.
|News Medical Life Sciences, 2016-12-09 06:24:21|
New research categorizes patients with depression into four unique subtypes
Patients with depression can be categorized into four unique subtypes defined by distinct patterns of abnormal connectivity in the brain, according to new research from Weill Cornell Medicine.
|News Medical Life Sciences, 2016-12-09 06:16:41|
Human migration study reveals new insights into cancer metastasis
What could cancer cells and drug-resistant bacteria possibly have in common with Stone Age settlers of the Americas? They're all migratory, and at one time or other, each finds the going a bit easier in a specific direction.
|News Medical Life Sciences, 2016-12-09 05:51:56|